CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study

Journal of Clinical Pharmacy and Therapeutics
S-W TangS-Y Zhan

Abstract

The pathogenic mechanism of antituberculosis drug-induced hepatotoxicity (ATDH) is thought to involve drug-metabolizing enzymes including N-acetyl transferase2 (NAT2), cytochrome P4502E1 (CYP2E1) and glutathione S-transferase (GST) M1, T1. The associations between genetic polymorphisms of those genes and ATDH have been reported but with inconsistent results. Moreover, most studies were hospital-based retrospective studies and not prospective. We aimed to investigate possible associations of CYP2E1, GSTM1 and GSTT1 genetic polymorphisms with ATDH using a more robust case-control study nested in a population-based prospective antituberculosis treatment cohort. A total of 4304 patients with smear-positive tuberculosis (TB) who received standard short-course chemotherapy were monitored for 6-9 months. Incidence density sampling method was adopted to select controls and 4 : 1 matched with each ATDH cases by age (± 5 years), sex, treatment history, disease severity and drug dosage. The CYP2E1, GSTM1 and GSTT1 polymorphisms were genotyped using PCR-RFLP and multiplex PCR methods. Conditional logistic regression model was used to calculate odds ratio (OR) and 95% confidence interval (CI), as well as corresponding P-values. A total of 8...Continue Reading

References

Feb 1, 1976·Annals of Internal Medicine·J R MitchellS D Nelson
Dec 18, 1996·Journal of the National Cancer Institute·A HirvonenH Vainio
Mar 18, 2000·Toxicology Letters·R C StrangeA A Fryer
Nov 15, 2000·Lancet·S R KnowlesN H Shear
Oct 24, 2001·American Journal of Respiratory and Critical Care Medicine·W J Burman, R R Reves
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yi-Shin HuangShou-Dong Lee
Feb 6, 2003·American Journal of Respiratory and Critical Care Medicine·Daphne YeeDick Menzies
Feb 18, 2003·American Journal of Respiratory and Critical Care Medicine·Henry M BlumbergUNKNOWN American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yi-Shin HuangShou-Dong Lee
May 29, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·P M FerreiraC Lopes
Apr 24, 2004·Cancer Letters·Joachim SchneiderHans-Joachim Woitowitz
Oct 6, 2006·American Journal of Respiratory and Critical Care Medicine·Jussi J SaukkonenUNKNOWN ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee
Oct 21, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Wing Wai Yew, Chi Chiu Leung
Jun 16, 2007·Biopharmaceutics & Drug Disposition·Helene J De RosaRosângela G P Machado
Nov 13, 2007·Journal of Gastroenterology and Hepatology·Alma TostmannRichard Dekhuijzen
Feb 29, 2008·Pharmacogenomics·Puspita Das RoyBidyut Roy
Apr 10, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Virginia LeiroArturo González-Quintela
Nov 7, 2009·Pharmacogenomics·Sang-Heon KimYoung-Koo Jee
Sep 22, 2010·Journal of Clinical Pharmacy and Therapeutics·S ChatterjeeS Kundu
Sep 24, 2010·Pharmacogenomics·Virginia Leiro-FernandezAlberto Fernández-Villar
Jan 26, 2011·Journal of Gastroenterology and Hepatology·Purabi Deka BosePremashis Kar
Mar 18, 2011·Clinical Pharmacology and Therapeutics·I G MetushiJ P Uetrecht
Oct 21, 2011·Memórias do Instituto Oswaldo Cruz·Raquel Lima de Figueiredo TeixeiraAdalberto Rezende Santos
Jan 1, 2006·Medical Journal, Armed Forces India·A C AnandP Puri

❮ Previous
Next ❯

Citations

Feb 5, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C LiY Zhou
Dec 4, 2015·Expert Review of Gastroenterology & Hepatology·Jonathan G Stine, James H Lewis
Oct 9, 2013·Clinics in Liver Disease·Jonathan G Stine, James H Lewis
Feb 26, 2013·Journal of Clinical Pharmacology·Alberto Corsini, Michele Bortolini
Feb 20, 2015·Archives of Toxicology·Ru ChenSiyan Zhan
Apr 20, 2016·The Pharmacogenomics Journal·N Ben FredjK Aouam
Mar 13, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Yun-Jian ShengCun-Liang Deng
Oct 2, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Débora Christina Ricardo Oliveira FernandesSidney Emanuel Batista Santos
Mar 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Konstantinos P Economopoulos, Theodoros N Sergentanis
Dec 14, 2016·Drug Metabolism Reviews·Nathalie K Zgheib, Robert A Branch
Apr 18, 2019·International Archives of Occupational and Environmental Health·Haiyue JiangYulong Lian
Jan 31, 2017·BioMed Research International·Alexander D Roth, Moo-Yeal Lee
May 28, 2016·Pharmacogenetics and Genomics·Daniel J KleinTeri E Klein
Jan 22, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·N Ben FredjK Aouam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.